Biologicals

Vaccine Standardization

The World Health Organization brings together international experts in specific fields through its biological standardization programme to develop and revise specific recommendations for the production and quality control of vaccines of major international public health importance. Authoritative, harmonized guidelines and recommendations, for use by manufacturers and regulatory authorities, are published in the reports of ECBS meetings in the WHO Technical Report Series. These include recommendations for individual vaccines, and also more general guidelines on technical or regulatory topics such as cell substrates, nonclinical evaluation, or clinical evaluation. This programme also establishes and distributes the WHO Biological Reference Materials required for the standardization of assays to laboratories around the world such as manufacturers and National Control Laboratories (NCLs) who are involved in the quality control of vaccines. This activity is critical to ensure the quality of essential vaccines in a global market.

Vaccine-specific standardization

General topics and regulatory guidance


Biological Therapeutic Products

UPCOMING EVENTS

WHO Collaborating Centers on Standardization on Regulatory Evaluation of Vaccines & Biotherapeutic Products: 1st meeting, Geneva, 24-26 April 2012

WHO Workshop on implementing WHO Guidelines on evaluating similar biotherapeutic products (SBPs), Xiamen, China, 28-30 May 2012

WHO Informal Consultation on the revision of the recommendations to assure the Quality, Safety and Efficacy of biological products prepared by recombinant DNA technology, Xiamen, China, 31 May-1 June 2012

CONTACTS

Quality, Safety and Standards (QSS)
Immunization, Vaccines and Biologicals (IVB)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971